Oman Serialization and Traceability Compliance

Discover OneScan

Global Regulations

Icon graphic element
Labelling

Products are required to display information in writing.

Summary

Pharmaceutical products in Oman are regulated by the Ministry of Health (MOH) through the Directorate General of Pharmaceutical Affairs and Drug Control (DGPA&DC). Oman has introduced barcode based identification requirements for medicines to improve product verification and strengthen pharmaceutical supply chain monitoring.

Oman aligns with GCC pharmaceutical identification standards, which encourage the use of GS1 compliant DataMatrix barcodes on pharmaceutical packaging. These barcodes enable unique identification of medicines and support verification during distribution and dispensing.

While Oman requires standardized barcode identification for medicines, the country does not currently operate a centralized national serialization reporting platform comparable to those implemented in some other GCC markets. Traceability oversight is primarily supported through product identification standards, supply chain documentation, and regulatory inspections.

Labelling Requirements 

Medicines marketed in Oman are expected to include a 2D DataMatrix barcode on the secondary packaging to support product identification within the pharmaceutical supply chain.

The DataMatrix barcode typically follows GS1 standards and includes the following data elements:

  • GTIN
  • Serial Number
  • Batch Number
  • Expiry Date

These identifiers allow each pharmaceutical package to be uniquely identified and verified during distribution and dispensing.

Human readable information printed on the packaging must correspond to the encoded barcode data.

Regulatory Timeline 

2017–2018
Oman began aligning pharmaceutical packaging and identification practices with GS1 barcode standards used across GCC countries.

2019 onward
Barcode identification requirements were introduced to support improved product verification and anti-counterfeiting efforts.

Current Status
Pharmaceutical products distributed in Oman are expected to include GS1 compliant barcodes for identification, while broader national traceability infrastructure continues to evolve.

Reporting Requirements 

Since Oman does not operate a centralized serialization platform, there are no mandatory electronic reporting requirements for serialized supply chain events such as commissioning, shipment, receiving, or dispensing.

Pharmaceutical companies are expected to maintain internal traceability records that allow regulators to verify product movement across the supply chain when required.

OperationData to ReportWhen to Report

Commission 
Aggregation 
Shipping 

GTIN, Serial, Batch, Expiry  
Parent SSCC, Child Serials  
Sender GLN, Receiver GLN, SSCC or Serial List
During packaging before shipment 
When creating cases or pallets 
Before dispatch 
ReceivingImport Clearance
Supply to Pharmacy
GTIN, Serial, Batch, Expiry  
Parent SSCC, Child Serials  
Sender GLN, Receiver GLN, SSCC or Serial List
During packaging before shipment 
When creating cases or pallets 
Before dispatch 
Returns 
Decommission 
Serial status and reference 
Reason and serials 
When return is approved 
When product is destroyed or removed 

Operational Timelines for Industry 

  • Ensure pharmaceutical products are registered with the Oman Ministry of Health before market entry.
  • Configure packaging lines to generate GS1 compliant DataMatrix barcodes.
  • Apply barcode identifiers to secondary packaging during manufacturing.
  • Ensure barcode data matches the product information printed on the packaging.
  • Maintain distribution and traceability records to support regulatory inspections.
  • Monitor regulatory updates related to future pharmaceutical traceability initiatives.

Reporting Hub

Oman does not currently operate a centralized pharmaceutical serialization reporting system.

Manufacturers and importers are required to ensure that medicines carry standardized barcodes compliant with GS1 identification standards. Supply chain traceability is maintained through internal company systems and distribution records rather than through a national reporting platform.

Regulatory authorities may verify product identification and distribution documentation during inspections.

Aggregation Requirements 

Oman’s current regulatory guidance focuses primarily on unit level product identification using DataMatrix barcodes.

Aggregation of pharmaceutical products at case or pallet level is not currently mandated by publicly available regulatory guidance. Pharmaceutical companies may implement aggregation internally to support logistics operations and warehouse management.

Common Errors to Avoid 

  • Failure to apply GS1 compliant barcodes to pharmaceutical packaging.
  • Incorrect configuration of DataMatrix barcode data elements.
  • Mismatch between barcode data and printed product information.
  • Incomplete supply chain documentation during product distribution.
  • Assuming Oman operates a centralized serialization reporting system similar to other GCC markets.

Trusted by Industry Leaders

Smooth and Successful

LSPedia didn’t just provide software; they ensured we were fully compliant. Anytime we had questions, the LSPedia team knew DSCSA inside and out and guided us step by step. That level of expertise made a huge difference during audits. Thanks to their expert team our audit was smooth and successful

Hussein Salman
Lead Pharmacist, Pioneer Pharmacy Services

Constant Commitment

LSPedia shows a constant commitment to improvement; whether it's their support or their product...they're always leveling up. The support team provides consistently thorough follow-up and clear, articulate communication. the support we receive represents a meaningful step up in service and is genuinely appreciated.

Zac Sweeny
EPCIS Data Encoder,Capital Wholesale Drug
Read All TestimonialsView Our Customers

Fill in the form for latest updates

Get in Touch

We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.

Contact Us